- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1 antibody
Total 53622 results
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingCarcinoma, Non-Small-Cell Lung | Lung Neoplasms | Carcinoma, Bronchogenic | Lung Disease | Respiratory Tract Disease | Respiratory Tract Neoplasms Nec | Neoplasm, BronchialChina
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Instituto Nacional de Cancerologia de MexicoUnknownNon-Small Cell Lung CancerMexico
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RecruitingRefractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy | MSI-H TumorsUnited States
-
The First Affiliated Hospital of Guangdong Pharmaceutical...University of Technology, Sydney; Guangzhou Anjie Biomedical Technology Co....UnknownNon-small Cell Lung Cancer | Lung Neoplasm MalignantChina
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin LymphomaUnited States, Brazil, Colombia, Czechia, France, Germany, Greece, Guatemala, Italy, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, United Kingdom
-
Fudan UniversityNot yet recruitingGastric Cancer | MSI-H | Adjuvant Therapy | PD-1 ImmunotherapyChina
-
Tongji UniversityRecruitingA Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver MutationsNSCLC, Stage IIIA | EGF-R Negative Non-Small Cell Lung Cancer | ALK Negative NSCLCChina
-
Dalian UniversityUnknownNon-small Cell Lung Cancer
-
Tongji HospitalNational Natural Science Foundation of ChinaRecruitingEsophageal Squamous Cell Carcinoma | Neoadjuvant TherapiesChina
-
Merck Sharp & Dohme LLCArray BioPharmaCompletedMetastatic Colorectal CancerUnited States, Canada
-
Cancer Hospital of Guangxi Medical UniversityRecruitingNasopharyngeal Carcinoma | SintilimabChina
-
National Cancer Institute (NCI)WithdrawnRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma
-
Shanghai Chest HospitalNot yet recruitingEsophageal CancerChina
-
Duke UniversityMerck Sharp & Dohme LLC; IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsUnited States
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingRectal Squamous Cell CarcinomaChina
-
UNC Lineberger Comprehensive Cancer CenterSyndax PharmaceuticalsCompletedMelanomaUnited States
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsBrazil, Canada, United States, United Kingdom, Taiwan, Australia, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Russian Federation, Singapore, Spain, Sweden, Turkey
-
Merck Sharp & Dohme LLCCompleted
-
Cairo UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingNeoplasmsPoland, United States, Australia, Canada, China, France, Greece, Israel, Japan, Korea, Republic of, South Africa, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Shandong New Time Pharmaceutical Co., LTDRecruiting
-
The First Affiliated Hospital of Zhengzhou UniversityActive, not recruiting
-
The First Affiliated Hospital of Guangdong Pharmaceutical...Guangzhou Anjie Biomedical Technology Co., Ltd.Unknown
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedSolid TumorUnited States
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
PfizerActive, not recruitingRenal Cell Carcinoma | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Squamous Cell Carcinoma of the Head and Neck | Bile Duct Cancer | Endometrial Cancer | Urothelial Cancer | Lung Squamous Cell Carcinoma | Melanoma CancerUnited States, Taiwan, Korea, Republic of, Australia, Slovakia
-
CureVacSyneos Health; Cromos Pharma LLCActive, not recruitingCarcinoma, Adenoid Cystic | Melanoma (Skin) | Squamous Cell Carcinoma of the Skin | Carcinoma, Squamous Cell of Head and NeckSpain, France, Austria, Germany, Russian Federation
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsFrance, Germany, Spain, United Kingdom
-
Second Affiliated Hospital, School of Medicine,...Westlake TherapeuticsRecruitingAdvanced Lung CancerChina
-
Zhongnan HospitalRecruitingHepatocellular Carcinoma; Targeted Therapy; Progression-free SurvivalChina
-
University of ChicagoWithdrawnHead and Neck CancerUnited States
-
Thomas MarronRecruiting
-
Xuhua DuanRecruiting
-
Yongchang ZhangRecruitingHER2 Insertion Mutation Positive Advanced NSCLCChina
-
Genentech, Inc.Completed
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Head and Neck Neoplasms | Colorectal NeoplasmsAustralia, Hong Kong
-
Adanate, IncRecruiting